Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Hematologic Transplantation and Malignancies
11:20

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Validation of the Composite CR Definitions in the IWG 2023 Criteria in Patients With HR-MDS Treated With HMAs"

FEATURING Jan Bewersdorf
  • 108 views
  • December 19, 2023
  • 1
11:00

ASH 2022 Conference Coverage

ASH 2022: Management of Accelerated and Blast-Phase MPN

FEATURING Raajit Rampal
  • 57 views
  • January 11, 2023
  • 2
23:13

MDS Foundation

MDS Foundation ASH 2021 Review: Towards a Genetically Inspired Classification of MDS

FEATURING Elsa Bernard
  • 73 views
  • January 24, 2022
11:04

ASH 2021 Conference Coverage on VuMedi

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with HR-MDS Treated With HMA Monotherapy in the 1L Setting

FEATURING Jan Bewersdorf
  • 123 views
  • December 23, 2021
  • 1
17:46

2021 International Congress on Myeloproliferative Neoplasms

Which Published Schemas Are Helpful in MPN Transplant Decisions?

FEATURING Sergio Giralt
  • 12 views
  • December 15, 2021
14:46

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Update on NY-ESO-1 TCR T-Cell Therapy

FEATURING Adam Schoenfeld
  • 44 views
  • October 1, 2021
10:40

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: A Tumor-Agnostic TCR-Mimic CAR T-Cell Specific for NDC80 Targets Multiple Hematological Malignancies

FEATURING Martin Klatt
  • 27 views
  • October 1, 2021
11:24

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

2021 SOHO Highlights on CARs for Solid Tumors

FEATURING Roisin O'Cearbhaill
  • 6 views
  • September 29, 2021
24:52

SOHO Highlights: State of the Art and Next Questions

CAR-T State of the Art: What Therapies Will Be Available in the Next 5 Years? Will CAR-T Replace Transplant?

FEATURING Sergio Giralt
  • 40 views
  • February 2, 2021
18:48

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on CARs: How Does the Ideal Next-Gen CAR T-Cell Look Like? What Is the Safety Profile of Novel Armored Cells?

FEATURING Renier Brentjens
  • 135 views
  • October 30, 2020
16:23

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Myelofibrosis: What Is the Distinctive Feature of MPN Pathogenesis? What Are the Prognostic Implications of Most Common Mutations? How Essential Is the Assessment of the Genomic Profile?

FEATURING Raajit Rampal
  • 358 views
  • October 20, 2020
  • 2
16:42

University of Miami's 2nd Biennial Miami Leukemia Symposium

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?

FEATURING Eytan Stein
  • 228 views
  • May 14, 2020
  • 1
40:55

Memorial Sloan Kettering Cancer Center

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and AlloHSCT, Overcoming AE of Mismatched HSCT, Prognostic Models & Conditioning Regimen Effects

FEATURING Miguel-Angel Perales
  • 45 views
  • March 25, 2020
23:23

Memorial Sloan Kettering Cancer Center

Complication of AlloHSCT: Phases of Complications, Classification of GVHD, Ruxolitinib for SR Acute GVHD, Ibrutinib Induces Responses in SR Chronic GVH & Phases of Opportunistic Infections

FEATURING Miguel-Angel Perales
  • 321 views
  • March 25, 2020
  • 1
17:30

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CNS Toxicity of CAR-T in Hematologic Malignancies: Clinical Manifestations, Who's at Risk and Why Does it Happen, New Grading Guidelines and Management

FEATURING Bianca Santomasso
  • 19 views
  • October 18, 2019
65:45

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Setting Up a CAR T Program Ins and Outs: Institutional Program Development

FEATURING Sergio Giralt
  • 29 views
  • October 17, 2019
23:38

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokine Release Syndrome and Neurotoxicity

FEATURING Bianca Santomasso
  • 31 views
  • October 16, 2019